[go: up one dir, main page]

ES506009A0 - Procedimiento para preparar una solucion no acuosa estable de una sal de antibiotico de tetraciclina. - Google Patents

Procedimiento para preparar una solucion no acuosa estable de una sal de antibiotico de tetraciclina.

Info

Publication number
ES506009A0
ES506009A0 ES506009A ES506009A ES506009A0 ES 506009 A0 ES506009 A0 ES 506009A0 ES 506009 A ES506009 A ES 506009A ES 506009 A ES506009 A ES 506009A ES 506009 A0 ES506009 A0 ES 506009A0
Authority
ES
Spain
Prior art keywords
tetracicline
preparing
procedure
aqueous solution
stable non
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES506009A
Other languages
English (en)
Other versions
ES8306995A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of ES8306995A1 publication Critical patent/ES8306995A1/es
Publication of ES506009A0 publication Critical patent/ES506009A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES506009A 1980-10-06 1981-10-05 Procedimiento para preparar una solucion no acuosa estable de una sal de antibiotico de tetraciclina. Granted ES506009A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19455680A 1980-10-06 1980-10-06
US06/262,475 US4376118A (en) 1980-10-06 1981-05-19 Stable nonaqueous solution of tetracycline salt

Publications (2)

Publication Number Publication Date
ES8306995A1 ES8306995A1 (es) 1983-06-16
ES506009A0 true ES506009A0 (es) 1983-06-16

Family

ID=26890152

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506009A Granted ES506009A0 (es) 1980-10-06 1981-10-05 Procedimiento para preparar una solucion no acuosa estable de una sal de antibiotico de tetraciclina.

Country Status (7)

Country Link
US (1) US4376118A (es)
EP (1) EP0049422B1 (es)
AU (1) AU527976B2 (es)
CA (1) CA1188615A (es)
DE (1) DE3173637D1 (es)
ES (1) ES506009A0 (es)
PH (1) PH17656A (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4701320A (en) * 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US5041278A (en) * 1985-10-15 1991-08-20 The Liposome Company, Inc. Alpha tocopherol-based vesicles
ATE82129T1 (de) * 1987-02-20 1992-11-15 Univ Emory Antiinfektioese verbindungen und verfahren zur verwendung.
US5674911A (en) * 1987-02-20 1997-10-07 Cytrx Corporation Antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use
US5811088A (en) * 1987-02-20 1998-09-22 Emory University Antiinfective compounds and methods of use
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
US6933286B2 (en) 1991-03-19 2005-08-23 R. Martin Emanuele Therapeutic delivery compositions and methods of use thereof
EP0576612B1 (en) * 1991-03-19 1999-12-01 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US7202225B1 (en) 1993-10-15 2007-04-10 Emanuele R Martin Therapeutic delivery compositions and methods of use thereof
USRE38558E1 (en) 1991-03-19 2004-07-20 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
US5691290A (en) * 1993-01-19 1997-11-25 Unichema Chemie B.V. Cleaning composition
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6645508B1 (en) 1999-06-18 2003-11-11 Jivn-Ren Chen Stable L-ascorbic acid composition
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2007140416A2 (en) 2006-05-30 2007-12-06 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
JP5048773B2 (ja) 2006-08-09 2012-10-17 インターシア セラピューティクス，インコーポレイティド 浸透圧式デリバリーシステム及びピストンアセンブリー
ES2315123B1 (es) * 2006-09-25 2009-12-30 Divasa-Farmavic, S.A. Composiciones farmaceuticas estables de tetraciclinas en solucion, procedimiento para su obtencion y sus usos.
WO2008097850A1 (en) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tretracycline compositions for topical administration
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
NZ580447A (en) 2007-04-23 2011-06-30 Intarcia Therapeutics Inc Suspension formulations of insulinotropic peptides and uses thereof
JP2010533187A (ja) 2007-07-11 2010-10-21 ダウ・コーニング・コーポレイション 薬物を送達するための組成物
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
RU2753280C2 (ru) 2009-09-28 2021-08-12 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
US20160287614A1 (en) 2013-11-20 2016-10-06 Lupin Limited Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
SG11201707784XA (en) 2015-03-23 2017-10-30 Biopharmx Inc Pharmaceutical tetracycline composition for dermatological use
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
CN109310743A (zh) 2016-05-16 2019-02-05 因塔西亚制药公司 胰高血糖素受体选择性多肽及其使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.
CN114428140A (zh) * 2022-01-26 2022-05-03 坛墨质检科技股份有限公司 一种叔丁基对苯二酚标准溶液配制方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3026248A (en) * 1959-09-11 1962-03-20 Pfizer & Co C Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents
US3389174A (en) * 1962-10-04 1968-06-18 American Cyanamid Co Stable tetracycline solutions
US3219529A (en) * 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US3140232A (en) * 1962-12-19 1964-07-07 Pfizer & Co C Color stabilization of tetracycline compositions with polypropylene glycols
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
BE790136R (fr) * 1971-11-29 1973-02-15 Esteve Labor Dr Nouveaux esters et hemi-esters des acides dicarboxyliques et procede depreparation de ces
US4000263A (en) * 1975-05-02 1976-12-28 Westwood Pharmaceuticals, Inc. Erythromycin solution

Also Published As

Publication number Publication date
EP0049422B1 (en) 1986-01-29
EP0049422A2 (en) 1982-04-14
ES8306995A1 (es) 1983-06-16
AU527976B2 (en) 1983-03-31
CA1188615A (en) 1985-06-11
DE3173637D1 (en) 1986-03-13
PH17656A (en) 1984-10-23
AU7603281A (en) 1982-07-15
US4376118A (en) 1983-03-08
EP0049422A3 (en) 1983-01-26

Similar Documents

Publication Publication Date Title
ES506009A0 (es) Procedimiento para preparar una solucion no acuosa estable de una sal de antibiotico de tetraciclina.
ES521728A0 (es) Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.
MX5697E (es) Procedimiento mejorado para la preparacion de una sal de sodio de n-fosfonometilglicina
ES498153A0 (es) Un procedimiento para eliminar li+ de una disolucion acuosa
ES500792A0 (es) Procedimiento para preparar derivados de cefalosporina
MX8481A (es) Procedimiento para preparar compuestos de carboestirilo.
ES520017A0 (es) Procedimiento de preparacion de una solucion de peracido carboxilico estable.
ES503606A0 (es) Procedimiento de produccion de 20-deoxo-4-semicaroriltilomiao de una sal de la misma.
AR224186A1 (es) Procedimiento para preparar una hidantoina
ES496747A0 (es) Un metodo para preparar una solucion acuosa de nitrogliceri-na
ES502980A0 (es) Un procedimiento para la preparacion de una macrolida
AR230634A1 (es) Procedimiento para preparar una solucion para inyeccion
ES505090A0 (es) Procedimiento para la preparacion de una coordinacion de compuesto de platero.
MX7115E (es) Procedimiento microbiologico para preparar acido 2,5-diceto-d-gluconico o una sal del mismo
ES521692A0 (es) Un procedimiento para la preparacion de (-)-(r)-1-hidroxi-2--(r-1-metil-3-fenilpropril-aminoetil-salicilamida o una sal de adicion de acido respectiva.
ES493915A0 (es) Un procedimiento para preparar una sal de tetrahidropiridi- nio
ES494808A0 (es) Un procedimiento para preparar una solucion oftalmica que contiene una sal de 2-acetil-7-(2-hidroxi-3-isopropilamino- propoxi) benzofurano.
ES502103A0 (es) Procedimiento para preparar una solucion hidrocarbonada de compuestos de dialquilmagnesio
NL7901242A (nl) Nieuwe gesubstitueerde 2-fenylimino-imidazolidinen, de zuuradditiezouten daarvan, de deze verbindingen bevat- tende preparaten en werkwijzen ter bereiding daarvan.
AR228869A1 (es) Procedimiento para preparar nuevos compuestos cefalosporanicos
ES517824A0 (es) Procedimiento para preparar derivados de cefalosporina.
ES499610A0 (es) Un procedimiento de preparacion de una sal cuaternaria de un ester de eritromicina.a.
ES500869A0 (es) Un procedimiento para la preparacion de una solucion concen-trada estable de cisplatin
ES497252A0 (es) Un procedimiento para preparar una solucion de sulfato de titanilo estable
AR225482A1 (es) Procedimiento para preparar una sal de bencimidazolina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203